Wird geladen...
SUN-179 Prolonged Hypoglycemia from Insulin Degludec
Prolonged Hypoglycemia from Insulin Degludec Background: Patients with type 2 diabetes treated with insulin degludec compared with insulin glargine had a reduced risk of overall symptomatic hypoglycemia (1). This is primarily due to former’s long half-life (25 hours) and lack of trough lev...
Gespeichert in:
| Veröffentlicht in: | J Endocr Soc |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Endocrine Society
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553236/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-179 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|